Details

MIPS - Quality Measures - ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication

Quality Measures
Category QUALITY
Description Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported. a. Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-Day Initiation Phase. b. Percentage of children who remained on ADHD medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.
eMeasure ID CMS136v6
First Performance Year 2017
Last Performance Year
Metric Type Multi Performance Rate
National Quality Strategy Domain ECC
Measure Type Process
eMeasure UUID 40280381-51f0-825b-0152-22a639d81762
NQF eMeasure ID
NQF ID 0108
Is High Priority?
Is Inverse?
Overall Algorithm simpleAverage
Primary Steward National Committee for Quality Assurance
Submission Methods Electronic Health Record
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://ecqi.healthit.gov/system/files/ecqm/measures/CMS136v6.html
Web Interface Measure Spec
Claims Measure Spec

Back to List